References
- SnymanJRDekkerJMalfeldSCKvan RensburgCEJPilot study to evaluate the safety and therapeutic efficacy of topical oxifulvic acid in atopic volunteerDrug Dev Res2002574043
- Van RensburgCEJMalfeldSCKDekkerJTopical application of oxifulvic acid suppresses the cutaneous immune response in miceDrug Dev Res2001532932
- van RensburgCEJVan StratenADekkerJAn in vitro investigation of the antimicrobial activity of oxifulvic acidJ Antimicrob Chemother20004685311062218
- VreyPJJansen van RensburgCEJCharacterization of a novel fulvic acid product derived from a safe, metal-free, naturally-occurring carbohydrate sourceData on file at Department of Pharmacology, University of PretoriaPretoria, South Africa
- LevinOLSilversSEThe reaction of the skin and its secretions in eczemaArch Derm Syphilol193225825834
- ChikakaneKTakahashiHMeasurement of skin pH and its significance in cutaneous diseasesClin Dermatol1995132993068665438
- BarbierNPaulCLugerTAllenRValidation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programmeBr J Dermatol20041509610214746622
- FaghihiGIrajiFShahingoharASaidatAHThe efficacy of ‘0.05% Clobetasol + 2.5% zinc sulphate’ cream vs ‘0.05% Clobetasol alone’ cream in the treatment of the chronic hand eczema: Double-blind studyJ Eur Acad Dermatol Venereol20082253153618284511